Sort
82,697 grants matching “vaccine development”
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$2,654,146Pamela J Bjorkman · California Institute Of Technology · P01 · FY2022 · AI
NCI-Frederick Support and Technical Services
$2,653,485Kristin Komschlies McConville · Office Of The Director, Nci · ZIC · FY2023 · CA
SPORE in Cervical Cancer
$2,651,995Johns Hopkins University · P50 · FY2005 · CA
Durban International Clinical Trials Unit
$2,651,567Umesh G Lalloo · Ukzn Innovation · U01 · FY2010 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$2,651,134Justin Ortiz · University Of Maryland Baltimore · N01 · FY2024 · AI
Center for Viral Systems Biology (CViSB)
$2,650,390Kristian Graugaard Andersen · Scripps Research Institute, The · U19 · FY2023 · AI
Mechanisms of naturally-acquired immunity to malaria
$2,650,143Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Optimizing malaria transmission-blocking vaccines with improved platforms
$2,649,684Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
SPORE in Prostate Cancer
$2,649,535Baylor College Of Medicine · P50 · FY2005 · CA
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,649,501David W Haas · Vanderbilt University Medical Center · UM1 · FY2024 · AI
Southeastern Sexually Transmitted Infections Cooperative Research Center
$2,649,057Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U19 · FY2011 · AI
Vaccine Induced Immunity in the Young and Aged
$2,649,051Rafi Ahmed · Emory University · U19 · FY2018 · AI
Southeastern Sexually Transmitted Infections Cooperative Research Center
$2,648,826Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE)
$2,646,688Devanand Sarkar · Virginia Commonwealth University · P01 · FY2025 · CA
Reagent Resource Support Program for AIDS Vaccine Development
$2,646,088Ronald Brown · Quality Biological, Inc. · N01 · FY2016 · AI
Soweto Clinical Trials Unit
$2,645,148James Alasdair McIntyre · Wits Health Consortium (Pty), Ltd · U01 · FY2008 · AI
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,644,556Scott M Hammer · Columbia University Health Sciences · UM1 · FY2012 · AI
Herpesvirus Pathogenesis and Vaccine Development
$2,643,536Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,642,740Stephen A Spector · University Of California, San Diego · UM1 · FY2014 · AI
SPORE in Prostate Cancer
$2,640,179Peter T Scardino · Sloan-Kettering Inst Can Research · P50 · FY2007 · CA
TASK ORDER B-15: Model Development and Medical Countermeasure Evaluation
$2,640,102Anthony Griffiths · Boston University Medical Campus · N01 · FY2023 · AI
Paving the Way for a Novel Therapeutic Approach to Combat HIV
$2,640,000Martin Prlic · Fred Hutchinson Cancer Research Center · DP2 · FY2012 · DE
HIV/SIV Data Base and Analysis Unit
$2,639,148National Institute Of Allergy And Infectious Diseases · Y01 · FY2014 · AI
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$2,639,002Matthias Johannes Schnell · Thomas Jefferson University · N01 · FY2017 · AI
Host Pathogen Variation & TB Pathogenesis
$2,638,886Thomas R Hawn · University Of Washington · U19 · FY2021 · AI